Participants 78 114 5
advanced non-small cell lung cancer:
Participants 273 352 5
patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
Participants 431 465 5
Patients in stage IIIB or IV NSCLC
Participants 784 866 4
105 (GA arm, 51; PG arm, 54) eligible patients (stage IV, 32 and 30, respectively)
